Search hospitals > Alabama > Birmingham
Veterans Affairs Medical Center - Birmingham
Claim this profileBirmingham, Alabama 35233
Global Leader in Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Leukemia
Conducts research for Cancer
Conducts research for Prostate Cancer
74 reported clinical trials
7 medical researchers
Summary
Veterans Affairs Medical Center - Birmingham is a medical facility located in Birmingham, Alabama. This center is recognized for care of Lung Cancer, Non-Small Cell Lung Cancer, Leukemia, Cancer, Prostate Cancer and other specialties. Veterans Affairs Medical Center - Birmingham is involved with conducting 74 clinical trials across 104 conditions. There are 7 research doctors associated with this hospital, such as Devika G. Das, Chen Lin, MD, Louis J Dellitalia, MD, and Ripu Jindal, MD.Area of expertise
1Lung Cancer
Global LeaderStage IV
ROS1 positive
BRAF positive
2Non-Small Cell Lung Cancer
Stage IV
ROS1 positive
BRAF positive
Top PIs
Devika G. DasVeterans Administration Medical Center - Birmingham2 years of reported clinical research
Studies Lung Cancer
Studies Cancer
4 reported clinical trials
10 drugs studied
Chen Lin, MDBirmingham VA Medical Center, Birmingham, AL2 years of reported clinical research
Studies Stroke
Studies Headache
3 reported clinical trials
8 drugs studied
Louis J Dellitalia, MDBirmingham VA Medical Center, Birmingham, AL1 year of reported clinical research
Studies Heart Failure
Studies High Blood Pressure (Hypertension)
1 reported clinical trial
1 drug studied
Ripu Jindal, MDBirmingham VA Medical Center, Birmingham, AL3 years of reported clinical research
Studies Sleep Disorders
Studies Insomnia
1 reported clinical trial
4 drugs studied
Clinical Trials running at Veterans Affairs Medical Center - Birmingham
Lung Cancer
Non-Small Cell Lung Cancer
Lung Adenocarcinoma
Heart Failure
Opioid Use Disorder
Myocardial Ischemia
Coronary Heart Disease
Coronary Artery Disease
Cancer
Lung Carcinoma
Sotorasib
for Non-Small Cell Lung Cancer
This phase II Lung-MAP treatment trial studies the effect of AMG 510 in treating non-squamous non-small cell lung cancer that is stage IV or has come back (recurrent) and has a specific mutation in the KRAS gene, known as KRAS G12C. Mutations in this gene may cause the cancer to grow. AMG 510, a targeted treatment against the KRAS G12C mutation, may help stop the growth of tumor cells.
Recruiting2 awards Phase 219 criteria
Targeted Therapy Screening
for Lung Cancer
This screening and multi-sub-study randomized phase II/III trial will establish a method for genomic screening of similar large cancer populations followed by assigning and accruing simultaneously to a multi-sub-study hybrid Master Protocol (Lung-MAP). The type of cancer trait (biomarker) will determine to which sub-study, within this protocol, a participant will be assigned to compare new targeted cancer therapy, designed to block the growth and spread of cancer, or combinations to standard of care therapy with the ultimate goal of being able to approve new targeted therapies in this setting. In addition, the protocol includes non-match sub-studies which will include all screened patients not eligible for any of the biomarker-driven sub-studies.
Recruiting1 award Phase 2 & 313 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Veterans Affairs Medical Center - Birmingham?
Veterans Affairs Medical Center - Birmingham is a medical facility located in Birmingham, Alabama. This center is recognized for care of Lung Cancer, Non-Small Cell Lung Cancer, Leukemia, Cancer, Prostate Cancer and other specialties. Veterans Affairs Medical Center - Birmingham is involved with conducting 74 clinical trials across 104 conditions. There are 7 research doctors associated with this hospital, such as Devika G. Das, Chen Lin, MD, Louis J Dellitalia, MD, and Ripu Jindal, MD.